Michael Hallensleben

1.1k total citations
41 papers, 697 citations indexed

About

Michael Hallensleben is a scholar working on Surgery, Immunology and Transplantation. According to data from OpenAlex, Michael Hallensleben has authored 41 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 18 papers in Immunology and 17 papers in Transplantation. Recurrent topics in Michael Hallensleben's work include Renal Transplantation Outcomes and Treatments (17 papers), T-cell and B-cell Immunology (12 papers) and Immune Cell Function and Interaction (11 papers). Michael Hallensleben is often cited by papers focused on Renal Transplantation Outcomes and Treatments (17 papers), T-cell and B-cell Immunology (12 papers) and Immune Cell Function and Interaction (11 papers). Michael Hallensleben collaborates with scholars based in Germany, United States and United Kingdom. Michael Hallensleben's co-authors include Rainer Blasczyk, Axel Seltsam, Michael P. Manns, Murielle Verboom, Martha M. Kirstein, Arndt Vogel, Frauke Metzler, J. Burkhart, J. Salman and W. Sommer and has published in prestigious journals such as Blood, Hepatology and Scientific Reports.

In The Last Decade

Michael Hallensleben

36 papers receiving 683 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Hallensleben Germany 15 273 227 191 183 149 41 697
Mariska Klepper Netherlands 17 134 0.5× 395 1.7× 217 1.1× 45 0.2× 44 0.3× 45 891
Simon C.D. Grant United Kingdom 8 159 0.6× 90 0.4× 86 0.5× 64 0.3× 42 0.3× 9 523
Rivka Shapiro Israel 12 194 0.7× 64 0.3× 156 0.8× 48 0.3× 84 0.6× 35 496
Mélanie Chesneau France 17 207 0.8× 484 2.1× 169 0.9× 38 0.2× 31 0.2× 29 907
Angus W. Thomson United States 10 198 0.7× 151 0.7× 62 0.3× 64 0.3× 63 0.4× 15 639
William H. Kitchens United States 13 266 1.0× 203 0.9× 143 0.7× 30 0.2× 96 0.6× 26 687
E. S. Curtoni Italy 14 121 0.4× 74 0.3× 100 0.5× 64 0.3× 37 0.2× 37 639
Angela Nocco Italy 13 307 1.1× 366 1.6× 102 0.5× 94 0.5× 21 0.1× 24 619
R. D. C. Forbes Canada 17 280 1.0× 188 0.8× 243 1.3× 20 0.1× 224 1.5× 42 810
Paul Brailey United States 13 481 1.8× 885 3.9× 117 0.6× 160 0.9× 46 0.3× 24 1.1k

Countries citing papers authored by Michael Hallensleben

Since Specialization
Citations

This map shows the geographic impact of Michael Hallensleben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hallensleben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hallensleben more than expected).

Fields of papers citing papers by Michael Hallensleben

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Hallensleben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hallensleben. The network helps show where Michael Hallensleben may publish in the future.

Co-authorship network of co-authors of Michael Hallensleben

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Hallensleben. A scholar is included among the top collaborators of Michael Hallensleben based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Hallensleben. Michael Hallensleben is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Verboom, Murielle, et al.. (2025). The New HLADRB1 *11:343 Allele Encoding for A Distinctive Peptide‐Binding Domain. HLA. 105(4). e70175–e70175.
2.
Verboom, Murielle, et al.. (2025). HLA‐C*15:02:01:69Q, A New Allele With A Different Splice Site. HLA. 105(3). e70126–e70126. 1 indexed citations
3.
Verboom, Murielle, et al.. (2025). The Novel HLA ‐B*38:123 Allele With A Unique M‐Leader Sequence. HLA. 105(4). e70166–e70166.
4.
Verboom, Murielle, et al.. (2025). HLA‐C*14:171 , a New Allele With a Rare Extracellular α3 Domain. HLA. 106(6). e70505–e70505.
7.
Verboom, Murielle, et al.. (2023). HLA‐C*07:1044N a novel allele, caused by a single nucleotide deletion in exon 3 of HLA‐C*07:01:01:01. HLA. 101(6). 687–688. 1 indexed citations
8.
Hallensleben, Michael, et al.. (2022). Impact of perioperative blood transfusions on postoperative renal function and survival after resection of colorectal liver metastases. World Journal of Surgical Oncology. 20(1). 1 indexed citations
9.
Avşar, M., J. Salman, Sebastián V. Rojas, et al.. (2022). Heart transplantation across preformed donor-specific antibody barriers using a perioperative desensitization protocol. American Journal of Transplantation. 22(8). 2064–2076. 11 indexed citations
10.
Reus, Bernhard, Stefano Caserta, Martin Larsen, et al.. (2021). In-Depth Profiling of T-Cell Responsiveness to Commonly Recognized CMV Antigens in Older People Reveals Important Sex Differences. Frontiers in Immunology. 12. 707830–707830. 14 indexed citations
11.
Höfer, Anne, Danny Jonigk, Björn Hartleben, et al.. (2020). Non-invasive screening for subclinical liver graft injury in adults via donor-specific anti-HLA antibodies. Scientific Reports. 10(1). 14242–14242. 23 indexed citations
12.
Pera, Alejandra, Stefano Caserta, Nadia Terrazzini, et al.. (2018). CD28null pro-atherogenic CD4 T-cells explain the link between CMV infection and an increased risk of cardiovascular death. Theranostics. 8(16). 4509–4519. 38 indexed citations
13.
Bräsen, Jan Hinrich, Jessica Schmitz, Wei Dai, et al.. (2017). Macrophage density in early surveillance biopsies predicts future renal transplant function. Kidney International. 92(2). 479–489. 58 indexed citations
14.
Juhl, David, Matthias Marget, Michael Hallensleben, Siegfried Görg, & Malte Ziemann. (2017). Assignment of C1q-binding HLA antibodies as unacceptable HLA antigens avoids positive CDC-crossmatches prior to transplantation of deceased donor organs. Transplant Immunology. 41. 17–21. 7 indexed citations
15.
Sommer, W., Michael Hallensleben, F. Ius, et al.. (2016). Repeated human leukocyte antigen mismatches in lung re-transplantation. Transplant Immunology. 40. 1–7. 4 indexed citations
16.
Junge, Norman, Murielle Verboom, Michael Hallensleben, et al.. (2015). Human leucocyte antigens and pediatric autoimmune liver disease: diagnosis and prognosis. European Journal of Pediatrics. 175(4). 527–537. 17 indexed citations
17.
Dobronravov, Vladimir, et al.. (2015). Long-Term Kidney Allograft Survival in Patients With Transplant Glomerulitis. Transplantation. 99(2). 331–339. 10 indexed citations
18.
Ius, F., W. Sommer, I. Tudorache, et al.. (2014). Preemptive treatment with therapeutic plasma exchange and rituximab for early donor-specific antibodies after lung transplantation. The Journal of Heart and Lung Transplantation. 34(1). 50–58. 30 indexed citations
19.
Verboom, Murielle, Michael Hallensleben, Peter A. Horn, & Rainer Blasczyk. (2007). Bioinformatic integration of biomechanics makes HLA sequencing universally applicable. Tissue Antigens. 70(4). 338–339. 10 indexed citations
20.
Seltsam, Axel, et al.. (2002). A weak blood group A phenotype caused by a new mutation at the ABO locus. Transfusion. 42(3). 294–301. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026